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Microalbuminuria is an early biomarker of general vascular dysfunction and a predictor of risk for cardiovascular and renal 
diseases. It is also considered as a marker of insulin resistance in both diabetic and non-diabetic patients. The rationale of this study 
was to elucidate threshold values of fasting blood glucose (FBS) and glycosylated hemoglobin (HbA1c) that are associated with 
microalbuminuria. In the parallel association of microalbuminuria with hyperhomocysteinemia was investigated. Machine learning 
algorithm and multiple linear regression were applied to study the association of poor glycemic control on microalbuminuria and 
hyperhomocysteinemia. In non-diabetic subjects with FBS <102 mg/dL and HbA1c <6.3%; and in diabetic subjects with good 
glycemic control (FBS: 102-118 mg/dL; HbA1c: 6.3-7.0%), urinary microalbumin levels were <40µg/mg creatinine. Poor 
glycemic control (FBS >172 mg/dL and HbA1c >9.0%) was associated with microalbumin >40µg/mg creatinine. Age, gender, 
HbA1c and FBS were shown to explain variability in urinary microalbumin to the extent of 54.4% as shown by multiple linear 
regression model. Analysis of variance (ANOVA) revealed higher levels of FBS (F: 39.77, P <0.0001), HbA1c (F: 64.31,  
P <0.0001) and total plasma homocysteine (F: 3.69, P =0.04) in microalbuminuria and clinical microalbuminuria groups when 
compared to subjects with normal microalbumin levels. Diabetic patients with poor glycemic index had a more B12 deficiency. Poor 
glycemic index and hyperhomocysteinemia were associated with clinical microalbuminuria.  
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India is emerging as the diabetes capital of the world 
with 62 million individuals affected with diabetes
1
. The 
global prevalence of microalbuminuria was reported to 
be 39%
2
. The duration of diabetes and HbA1c levels 
were reported to have positive association with urinary 
microalbumin levels
3,4
. Urinary proteome analysis of 
microalbuminuria cases revealed α2-HS-glycoprotein, 
vitamin D binding protein, CD59, an extracellular 
matrix protein 1 (ECM1), factor H and myoglobin
5
. The 
α2-HS-glycoprotein was associated with functions such 
as endocytosis, brain development and formation of 
bone tissue. Vitamin D binding protein binds  
vitamin D2, vitamin D3 and their 25-hydroxylated forms 
and facilitates their transport across different tissues. 
CD59 causes microvesicular damage while ECM1  
and factor H influence mesangial cell proliferation.  
25-hydroxy vitamin D deficiency was reported to be 
associated with diabetes and renal disease
6
. 
A recent study showed elevated plasma homocysteine 
levels in type II diabetes mellitus and this elevation 
increases further due to increased insulin resistance and 
poor glycemic control
7
. In healthy adults, plasma 
homocysteine was reported to be positively associated 
with microalbumin in men
8
.
 
Patients with type II 
diabetes, long-term treatment with metformin and 
smoking were shown to have a higher prevalence of 
vitamin B12 deficiency
9
. B12 supplementation in children 
was shown to influence the regulation of several 
metabolically important type II diabetes-associated 
genes through methylation of miR 21
10
. 
In view of the positive association of diabetes and 
HbA1c with microalbuminuria, the association of 
treatment-induced vitamin B12 deficiency in type II 
diabetes, the current study was planned to investigate 
the thresholds of fasting blood glucose, HbA1c  
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and total plasma homocysteine associated with 
microalbuminuria and clinical microalbuminuria.  
 
Materials and Methods 
 
Recruitment of subjects 
We have enrolled a total of 975 subjects, which 
includes 873 diabetic patients (514 men and  
359 women) and 102 non-diabetic controls (57 men 
and 45 women) at the out-patient unit of Nizam’s 
Institute of Medical Sciences, Hyderabad, India.  
The mean ages in diabetic and non-diabetic patients 
were 60.6±13.1 year and 58.9±10.5, respectively. The 
study protocol was approved by the Institutional 
Ethical committee of Nizam’s Institute of Medical 
Sciences, Hyderabad, India. All the enrolled subjects 
consented for the study. 
 
Biochemical evaluation 
Blood glucose levels were estimated by hexokinase 
method using Roche Cobas c501 fully automated 
chemistry analyzer (Roche Diagnostics, U.S.A.). 
HbA1c levels were estimated by using the  
Bio-Rad D-10TM Dual Program intended for the 
percent determination of HbA1c in human  
whole blood using ion-exchange high-performance 
liquid chromatography (HPLC). The samples are 
automatically diluted on the D-10 and injected into 
the analytical cartridge. The D-10 delivers a 
programmed buffer gradient of increasing ionic 
strength to the cartridge, where the hemoglobins are 
separated based on their ionic interactions with the 
cartridge material. The separated hemoglobins then 
pass through the flow cell of the filter photometer, 
where changes in the absorbance 415 nm are 
measured. The A1c area is calculated using an 
exponentially modified Gaussian (EMG) algorithm 
that excludes the labile A1c and carbamylated peak 
area from the A1c peak area. Immunoturbidimetric 
assay on Roche Coas c501 analyzer was used to 
estimate urinary microalbumin levels. Anti-albumin 
antibodies react with the antigen in the sample to form 
antigen/antibody complexes which, following 
agglutination, are measured turbidimetrically. 
Vitamin B12, Folate and Homocysteine assays are 
performed on ADVIA Centaur® XP Immunoassay 
system using kits manufactured by Simens Healthcare 
Diagnostics Inc., U.S.A.  
 
Statistical analysis 
Student t-test was performed for bivariate and 
ANOVA was performed for trivariate datasets of 
continuous variables. Tetraplot software was used to 
plot trivariate models. The multiple linear regression 
model was developed using age, gender, FBS, HbA1c 
and diabetic status as the predictors and urinary 
microalbumin levels as the output using 
www.wessa.net. The association statistics were based 
on a machine learning algorithm developed using the 
computational software “www.bigml.com”. 
 
Results 
The diabetic subjects had elevated microalbumin 
levels in comparison to non-diabetic subjects 
(79.0±185 vs. 3.51±1.55 µg/mg creatinine, P <0.0001). 
The FBS levels in non-diabetic subjects were  
97.17 ± 13.7 mg/dL. The FBS levels in diabetic 
patients were segregated based on HbA1c levels as 
shown below: HbA1c<6.0%: 112.29 ± 26.9 mg/dL; 
HbA1c: 6.0-8.0 %: 125.30 ± 29.7 mg/dL; HbA1c 
>8.0-10.0%: 161.57 ± 51.9 mg/dL; and HbA1c 
>10.0%: 234.29 ± 81.3 mg/dL. Analysis of variance 
(ANOVA) revealed that FBS levels are associated 
with glycosylated hemoglobin (F: 187.3, P <0.0001). 
The microalbumin data was segregated into  
normal microalbumin (<30 µg/mg creatinine), 
microalbuminuria (30-300 µg/mg creatinine) and 
clinical microalbuminuria (>300 µg/mg creatinine). 
Further, segregation was done based on glycosylated 
hemoglobin. All cases of microalbuminuria were 
shown to have glycosylated hemoglobin >6.0 except 
one. The prevalence of microalbuminuria in subjects 
with HbA1C levels 6.0-8.0%, >8.0-10.0% and >10% 
were 26.3%, 33.7% and 66.0%, respectively,  
(2: 87.98, P <0.0001) while the prevalence of 
clinical microalbuminuria were 5.9%, 10.1% and 
29.8%, respectively, (2: 14.54, P =0.0001). 
The fasting blood glucose levels were within  
the renal threshold range in normal microalbumin 
group i.e.131.69 ±43.9 mg/dL. In microalbuminuria 
and clinical microalbuminuria the FBS levels are 
163.73 ± 70.0 mg/dL and 171.79 ± 86.9 mg/dL, 
respectively, (F: 39.77, P <0.0001). Trivariate plot 
(Fig. 1) clearly demonstrates that in subjects with 
HbA1c <6.0% and fasting blood glucose within  
the renal threshold limit, there was no association 
with microalbuminuria.  
As illustrates in (Fig. 2), B12 deficiency was 
associated with poor glycemic index while folate 
status has no association. Clinical microalbuminuria 
was shown to be associated with HbA1c >8% and 
homocysteine >32 µM/L (Fig. 3).  
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Fig. 1 — Association of Glycosylated hemoglobin and Fasting 
blood sugar with urinary microalbumin. This clearly illustrates 
that Glycosylated hemoglobin <6.0% and Fasting blood sugar 
<100 mg/dL is not associated with microalbuminuria 
 
 
 
Fig. 2 — Association of B12 and folate with glycemic index.  
This illustrates that low B12 status is associated with the 
poor glycemic index while folate status has no influence on  
the glycemic index 
 
 
 
Fig. 3 — Association of homocysteine and HbA1c with 
microalbuminuria. This illustrates that clinical microalbuminuria 
is associated with poor glycemic index (HbA1c > 8%) and 
elevated homocysteine (>32 uM/L) 
 
 
 
Fig. 4 — Correlation of experimental microalbumin levels with 
predictions based on multiple linear regression. The experimental 
microalbumin levels were correlated with multiple linear 
regression based predicted values (r2: 0.544) 
 
Furthermore, we have deduced the following 
equation to depict the contribution of different 
variables towards urinary microalbumin using the 
multiple linear regression model:  
Log 10 (Urine microalbumin) = −0.237477 + 
[0.00288253×age] + [0.0442243×gender] + 
[0.0811325×glycosylated hemoglobin] + 
[0.000990878×Fasting blood sugar] + 
[0.589106×diabetic]  
This model explained 54.4% variability in urinary 
microalbumin (Fig. 4). The association statistics  
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of machine learning algorithm reveal that  
non-diabetic subjects with FBS <102 mg/dL and  
Hb1Ac <6.32%; and diabetic subjects with FBS  
in the range of 102-118 mg/dL and HbA1c  
6.32-7.06% will have microalbumin levels <40 µg/mg 
creatinine. Subjects with uncontrolled diabetes i.e. 
FBS>171.8 mg/dL and HbA1c >9.03% are associated 
with microalbumin >40 µg/mg creatinine (Fig. 5).  
 
Discussion 
The current study adds a new dimension to the 
already documented association of poor glycemic 
index and microalbuminuria by providing the 
thresholds of fasting blood glucose and HbA1c  
that are strongly associated with microalbuminuria.  
In order to establish these thresholds, machine 
learning algorithms were used for the first time.  
FBS >172 mg/dL and HbA1c >9.0 are associated with 
urine microalbumin >40 µg/mg creatinine. This is in 
agreement with another Indian study that 
demonstrated an increase in microalbumin levels with 
an increase in HbA1c
11
. 
The renal threshold of glucose in type II diabetes 
patients was reported to vary based on age, disease 
duration and body mass index
12
. A large-scale study 
demonstrated that urinary albumin-creatinine ratio, 
age, weight, HbA1c, blood glucose, total cholesterol, 
antihypertensive drugs and heart rate as the key 
determinants of microalbuminuria in diabetes 
patient
13
, which is in agreement with our multiple 
linear regression model. Another large-scale study 
applied multiple logistic regression model and 
demonstrated that microalbuminuria was associated 
with hyperglycemia and HbA1c in the non-obese 
group; and hypertension and HbA1c in the obese 
group in younger subjects
14
. Even in prediabetic 
subjects who have a genetic predisposition to diabetes 
due to Glucokinase (GCK) rs2908289, fasting blood 
glucose was associated with microalbuminuria even 
after adjusting for confounding factors such as age, 
gender, smoking, systolic blood pressure, waist 
circumference and serum triglycerides
15
. Prediabetic 
subjects were reported to have interleukin-6 (IL-6) 
and hyperinsulinemia indicating subclinical 
inflammation and insulin resistance even in 
prediabetic period
16
. Strong positive association was 
observed between IL-6 and insulin in these subjects
16
. 
Consistent with our study, total plasma 
homocysteine levels were found to be higher in 
diabetic subjects and were positively associated with 
microalbuminuria
17
. Higher incidence of B12 deficiency 
was reported in the elderly population, with longer 
diabetes mellitus duration, hypothyroidism and 
treatment with metformin
18
. Our results are in 
agreement with Passaro et al., in demonstrating 
association of poor glycemic control with 
hyperhomocysteinemia
19
. Subjects with 
microalbuminuria were reported to have higher blood 
pressure and homocysteine levels compared to those 
with normal microalbumin levels
20
. Dietary glycemic 
index was shown to have a positive association with 
homocysteine
21
. In type II diabetes patients, renal 
mishandling of thiamine increased degradation of 
vitamin B6 and cytosolic metabolic resistance to 
vitamin B12 was reported
22
. A recent meta-analysis 
reported normal homocysteine levels in type I DM 
patients without any complications, however, in 
subjects with T1DM associated microvascular 
complications, such as diabetic retinopathy and 
diabetic neuropathy, hyperhomocysteinemia was 
observed
23
. In subjects with type II diabetes, the 
baseline plasma homocysteine and mean HbA1c levels 
were reported to be independent predictors of 
microalbuminuria
24
. 
The strength of the current study are: (i) large 
sample size; (ii) application of multiple linear 
regression to understand the contribution of  
different variables towards microalbuminuria; (iii) 
establishment of thresholds of fasting blood glucose 
and HbA1c that contribute to microalbuminuria. The 
limitations are: (i) diabetes subjects were not grouped 
into type I or type II diabetes; (ii) information on diet 
 
 
Fig. 5 — Association statistics of microalbuminuria based  
on a machine learning algorithm. The association statistics reveal 
that non-diabetic subjects with FBS <102 mg/dL and  
Hb1Ac <6.32; and diabetic subjects with FBS in the range of  
102-118 mg/dL and HbA1c 6.32-7.06% will have microalbumin 
levels <40 µg/mg creatinine. Subjects with uncontrolled diabetes 
i.e. FBS >171.8 and HbA1C >9.03% are associated with 
microalbumin >40 µg/mg creatinine 
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and other lifestyle risk factors were not available. 
Future studies are warranted to investigate whether 
type I and type II diabetes subjects behave differently 
towards microalbuminuria.  
 
Conclusion 
Subjects with FBS >172 mg/dL and HbA1c >9.0% 
are associated with urine microalbumin >40 µg/mg 
creatinine. B12 deficiency was observed in subjects 
with poor glycemic index. Clinical microalbuminuria is 
associated with hyperhomocysteinemia (>32 µM/L). 
 
References 
1 Joshi SR, Diabetes care in India. Ann Glob Health, 81 (2015) 
830. 
2 Parving HH, Lewis JB, Ravid M, Remuzzi G & Hunsicker LG, 
Prevalence and risk factors for microalbuminuria in a 
referred cohort of type II diabetic patients: a global 
perspective. Kidney Int, 69 (2006) 20573.  
3 Aggarwal J & Kumar M, Prevalence of microalbuminuria 
among rural north indian population with diabetes mellitus 
and its correlation with glycosylated haemoglobin and 
smoking. J Clin Diagn Res, 8 (2014) CC11. 
4 Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E & 
Ray D, Relation of microalbuminuria to glycosylated 
hemoglobin and duration of type 2 diabetes. Niger J Clin 
Pract, 16 (2013) 216. 
5 Marikanty RK, Gupta MK, Cherukuvada SV, Kompella SS, 
Prayaga AK, Konda S, Polisetty RV, Idris MM, Rao PV, 
Chandak GR & Dakshinamurty KV, Identification of urinary 
proteins potentially associated with diabetic kidney disease. 
Indian J Nephrol, 26 (2016) 434. 
6 Mohan IK, Khan SA, Jacob R, Sai Baba KSS, Hussain T, 
Alrokayan SA & Naushad SM, Insights into the association 
of vitamin d deficiency with parathyroid hormone levels with 
relevance to renal function and insulin resistance. Curr Nutr 
Food Sci, 13 (2017) 1.  
7 Ala OA, Akintunde AA, Ikem RT, Kolawole BA, Ala OO & 
Adedeji TA, Association between insulin resistance and total 
plasma homocysteine levels in type 2 diabetes mellitus 
patients in south west Nigeria. Diabetes Metab Syndr, 11 
suppl 2 (2017) S803.  
8 Sabanayagam C & Shankar A, Association between plasma 
homocysteine and microalbuminuria in persons without 
hypertension, diabetes mellitus, and cardiovascular disease. 
Clin Exp Nephrol, 15 (2011) 92. 
9 Khan A, Shafiq I, Hassan Shah M. Prevalence of Vitamin 
B12 deficiency in patients with type ii diabetes mellitus on 
metformin: a study from khyber pakhtunkhwa. Cureus, 9 
(2017) e1577. 
10 Yadav DK, Shrestha S, Lillycrop KA, Joglekar CV, Pan H, 
Holbrook JD, Fall CH, Yajnik CS & Chandak GR, Vitamin 
B12 supplementation influences methylation of genes 
associated with Type 2 diabetes and its intermediate traits. 
Epigenomics, 10 (2018) 71. 
11 Poornima MA, Shenoy R & Hegde A, Laboratory assessment 
of the diabetes scenario with respect to hba1c and 
microalbuminuria. J Clin Diag Res, 4 (2010) 2489. 
12 Yue XD, Wang JY, Zhang XR, Yang JH, Shan CY,  
Zheng MY, Ren HZ, Zhang Y, Yang SH, Guo ZH, Chang B 
& Chang BC, Characteristics and impact factors of renal 
threshold for glucose excretion in patients with type 2 
diabetes mellitus. J Korean Med Sci, 32 (2017) 621. 
13 Chatzikyrkou C, Menne J, Izzo J, Viberti G, Rabelink T, 
Ruilope LM, Rump C, Mertens PR & Haller H, Predictors 
for the development of microalbuminuria and interaction 
with renal function. J Hypertens, 35 (2017) 2501. 
14 Cho H & Kim JH, Prevalence of microalbuminuria and its 
associated cardiometabolic risk factors in Korean youth: 
Data from the Korea National Health and Nutrition 
Examination Survey. PLoS One, 12 (2017) e0178716. 
15 Choi JW, Moon S, Jang EJ, Lee CH & Park JS, Association 
of prediabetes-associated single nucleotide polymorphisms 
with microalbuminuria. PLoS One, 12 (2017) e0171367. 
16 Agarwal A, Hegde A, Yadav C, Ahmad A, Manjrekar PA & 
Rukmini MS, Interleukin-6 in impaired fasting glucose. 
Indian J Biochem Biophys, 55 (2018) 424. 
17 Ozmen B, Ozmen D, Turgan N, Habif S, Mutaf I & Bayindir O, 
Association between homocysteinemia and renal function in 
patients with type 2 diabetes mellitus. Ann Clin Lab Sci, 32 
(2002) 279. 
18 Tavares Bello C, Capitão RM, Sequeira Duarte J, Azinheira J 
& Vasconcelos C, Vitamin B12 deficiency in type 2 diabetes 
mellitus. Acta Med Port, 30 (2017) 719. 
19 Passaro A, Calzoni F, Volpato S, Nora ED, Pareschi PL, 
Zamboni PF, Fellin R & Solini A, Effect of metabolic control 
on homocysteine levels in type 2 diabetic patients: a 3-year 
follow-up. J Intern Med, 254 (2003) 264. 
20 Kuang ZM, Wang Y, Feng SJ, Jiang L & Cheng WL, 
Association between plasma homocysteine and 
microalbuminuria in untreated patients with essential 
hypertension: a Case-Control Study. Kidney Blood Press 
Res, 42 (2017) 1303. 
21 Murakami K, Sasaki S & Uenishi K, Japan dietetic students’ 
study for nutrition and biomarkers group. dietary glycemic 
index, but not glycemic load, is positively associated with 
serum homocysteine concentration in free-living young 
japanese women. Nutr Res, 34 (2014) 25. 
22 Adaikalakoteswari A, Rabbani N, Waspadji S, 
Tjokroprawiro A, Kariadi SH, Adam JM & Thornalley PJ, 
Disturbance of B-vitamin status in people with type 2 
diabetes in Indonesia--link to renal status, glycemic control 
and vascular inflammation. Diabetes Res Clin Pract, 95 
(2012) 415. 
23 Feng Y, Shan MQ, Bo L, Zhang XY & Hu J, Association of 
homocysteine with type 1 diabetes mellitus: a meta-analysis. 
Int J Clin Exp Med, 8 (2015) 12529. 
24 Cho EH, Kim EH, Kim WG, Jeong EH, Koh EH, Lee WJ, 
Kim MS, Park JY & Lee KU, Homocysteine as a risk factor 
for development of microalbuminuria in type 2 diabetes. 
Korean Diabetes J, 34 (2010) 200. 
 
 
